右腋下小切口在先天性心脏病手术中的应用:经皮插管分析
单中心回顾分析110例16岁以下双心室先心病患儿,采用右腋垂直小切口(4-5 cm)行动脉/双腔静脉插管体外循环;2016年起下腔静脉改经股静脉经皮穿刺插管。随访14.4个月无早晚期死亡,无伤口感染或胸廓畸形,股静脉穿刺部位血栓5例(13.5%)。
要点
- 右腋垂直小切口可用于新生儿及幼儿常见先心病矫治,美容效果好
- 股静脉经皮插管可提供足够体外循环流量,即使婴儿术后早期肝素预防也可使用
- 股静脉穿刺部位血栓见于5例(13.5%),需关注插管部位并发症
核心结论
- 右腋垂直小切口可作为新生儿和幼儿常见先心病修复的微创、美观替代入路。
- 股静脉经皮插管能提供足够体外循环流量,术后早期肝素预防下仍可使用。
研究设计与样本
- 回顾性单中心分析,纳入5年间接受右腋垂直小切口矫治手术的16岁以下患儿。
- 共110例双心室先天畸形患儿,年龄2.3岁(范围0.2-16),体重11 kg(范围3-47)。
- 切口为平行腋前皱襞的4-5 cm垂直切口,行主动脉/双腔静脉插管;2016年起下腔静脉改用股静脉经皮穿刺插管。
主要发现
- 体外循环时间66分钟(范围24-167),主动脉阻断时间41分钟(范围9-95)。
- 手术台上拔管快速通道管理占34.5%(n=38)。
- 股静脉经皮插管38例(34.5%)中,穿刺部位血栓5例(13.5%)。
- 随访14.4个月(范围0.8-47.19)无早晚期死亡,未见伤口感染或胸廓畸形。
临床怎么用
- 对合适的新生儿及幼儿先心病矫治可考虑右腋垂直小切口,兼顾微创与美观。
- 采用股静脉经皮插管建立体外循环时需警惕穿刺部位血栓,术后早期肝素预防可考虑使用。
局限性
- 为单中心回顾性分析,样本量110例,结果外推需谨慎。
- 随访时间中位14.4个月,远期结局如胸廓发育等尚未充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vertical right axillary minithoracotomy (VRAMT) represents a minimally invasive and cosmetically attractive alternative for selected congenital heart defects. We report our institutional experience with VRAMT, especially regarding the performance of percutaneous femoral venous access to establish extracorporeal circulation in this pediatric population. METHODS: A retrospective single-center analysis was made of children to 16 years of age who underwent corrective cardiac surgery using VRAMT over a period of 5 years. VRAMT involved a 4 cm to 5 cm vertical incision parallel to the anterior axillary fold and aortic/bicaval cannulation. Since 2016, the technique has been modified and the inferior vena cava was cannulated using femoral percutaneous venous access. The primary endpoints were all-cause mortality, with additional secondary endpoints of major adverse cardiac and cerebrovascular events and conversion to median sternotomy. RESULTS: A total of 110 patients with biventricular congenital malformations were included. Age was 2.3 years (range, 0.2 to 16), and body weight was 11 kg (range, 3 to 47). Extracorporeal circulation time was 66 minutes (range, 24 to 167), cross-clamp time was 41 minutes (range, 9 to 95). Fast-track-management with on-table extubation was achieved in 34.5% (n = 38). For patients with percutaneous femoral venous cannulation (n = 38, 34.5%), thrombosis at the cannulation site was recorded in 5 cases (13.5%). There was no early or late mortality during the follow-up of 14.4 months (range, 0.8 to 47.19). No wound infection or thoracic deformities were observed. CONCLUSIONS: VRAMT can be considered as an alternative, minimally invasive, and cosmetically attractive access for the repair of frequent congenital heart defects in newborns and young children. Percutaneous femoral venous cannulation provides sufficient extracorporeal circulation flow and can be used even in infants with early postoperative heparin prophylaxis.
引用
- Heinisch PP, Bartkevics M, Beck MJ, et al. Right Axillary Thoracotomy in Congenital Cardiac Surgery: Analysis of Percutaneous Cannulation. Ann Thorac Surg. 2020. PMID: 33159866. doi:10.1016/j.athoracsur.2020.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。